Tevogen Bio Inc. (TVGN)
NASDAQ: TVGN
· Real-Time Price · USD
0.67
-0.11 (-14.04%)
At close: Oct 03, 2025, 3:59 PM
0.68
0.27%
After-hours: Oct 03, 2025, 07:43 PM EDT
-14.04% (1D)
| Bid | 0.65 |
| Market Cap | 132.56M |
| Revenue (ttm) | 396.59K |
| Net Income (ttm) | -31.2M |
| EPS (ttm) | -0.19 |
| PE Ratio (ttm) | -3.55 |
| Forward PE | -3.25 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 0.7 |
| Volume | 1,718,143 |
| Avg. Volume (20D) | 841,612 |
| Open | 0.76 |
| Previous Close | 0.78 |
| Day's Range | 0.65 - 0.79 |
| 52-Week Range | 0.26 - 3.09 |
| Beta | -0.81 |
| Ex-Dividend Date | n/a |
About TVGN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TVGN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for TVGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+7.74%
Tevogen Bio Holdings shares are trading higher aft...
Unlock content with
Pro Subscription
5 months ago
-5.52%
Tevogen Bio Holdings shares are trading higher after the company reaffirmed its oncology pipeline revenue forecast, projecting $1 billion in its launch year and a cumulative five-year estimate of $10 billion to $14 billion.
